Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prokineticin-1
(
PK1
) is a recently described protein with a wide range of functions, including tissue-specific angiogenesis, modulation of inflammatory responses, and regulation of hemopoiesis. The aim of this study was to investigate the localization and expression of
PK1
and PK receptor-1 (PKR1), their signaling pathways, and the effect of
PK1
on expression of the inflammatory mediators cyclooxygenase (COX)-2 and
IL-8
in third-trimester placenta.
PK1
and PKR1 were highly expressed in term placenta and immunolocalized to syncytiotrophoblasts, cytotrophoblasts, fetal endothelium, and macrophages.
PK1
induced a time-dependent increase in expression of
IL-8
and COX-2, which was significantly reduced by inhibitors of Gq, cSrc, epidermal growth factor receptor (EGFR), and MAPK kinase. Treatment of third-trimester placenta with 40 nm
PK1
induced a rapid phosphorylation of cSrc, EGFR, and ERK1/2. Phosphorylation of ERK1/2 in response to
PK1
was dependent on sequential phosphorylation of cSrc and EGFR. Using double-immunofluorescent immunohistochemistry, PKR1 colocalized with
IL-8
and COX-2 in placenta. These data suggest that
PK1
may have a novel role as a mediator of the inflammatory response in placenta.
...
PMID:Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta. 1837 30
Prokineticin 1 and 2 (
PROK1
and PROK2) are two small proteins largely expressed in inflammatory tissues and involved in monocyte activation and differentiation. The focus of this study was to evaluate whether
PROK1
was able to induce chemokine secretion in human monocytes, in monocyte-derived macrophages and in monocyte-derived dendritic cells, an aspect not addressed thus far. Here, we show for the first time, using flow cytometry, that PROK receptors 1 and 2 are present on the surface of human monocytes. Subsequently, monocytes were selected to investigate the chemokine response after stimulation by
PROK1
. Our results show that only three chemokines (CCL4, CXCL1 and
CXCL8
) were significantly induced at both the transcript and protein level, and that
PROK1
induces most potently
CXCL8
, in a dose-dependent manner. From a mechanistic point of view, by blocking independently Galphai protein or intracellular calcium, monocytes lose the ability to secrete
CXCL8
in response to
PROK1
. Finally, we observed that CCL4, CXCL1 and
CXCL8
secretion, following
PROK1
induction, is only observed in monocytes and not in monocyte-derived macrophages and dendritic cells. Our results demonstrate that, in vitro, the differentiation status of monocytes influences chemokine production after stimulation by
PROK1
, and that this chemokine production is geared toward a pro-inflammatory response. This could represent a novel amplification loop of leukocyte recruitment, extravasation and tissue invasion.
...
PMID:Prokineticin 1 induces CCL4, CXCL1 and CXCL8 in human monocytes but not in macrophages and dendritic cells. 1910 22